サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1526381

顔用注射剤の世界市場、シェア、規模、動向、産業分析レポート：製品別、用途別、最終用途別、地域別情報 - 2024年～2032年の市場予測

Global Facial Injectable Market Share, Size, Trends, Industry Analysis Report: Information By Product, By Application, By End-Use, And By Region - Market Forecast, 2024 - 2032

出版日
ページ情報
英文 117 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
顔用注射剤の世界市場、シェア、規模、動向、産業分析レポート：製品別、用途別、最終用途別、地域別情報 - 2024年～2032年の市場予測
出版日: 2024年07月01日
発行: Polaris Market Research
ページ情報: 英文 117 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Researchの最新調査によると、顔用注射剤の世界市場規模は2032年までに336億3,000万米ドルに達する見込みです。このレポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

費用対効果の高い施術の導入が市場の需要を大幅に拡大したため、顔用注射剤の需要が急速に高まっています。製品は、高額な費用をかけずに審美的な強化を求める消費者に利用しやすい選択肢を提供するため、顧客層が広がり、市場全体の浸透率が高まっています。

さらに、顔用注射剤の需要拡大は、安全性と有効性を保証し、より幅広い消費者にとって治療がより身近で魅力的なものとなるよう、規制当局の承認が増加したことが背景にあります。例えば、2023年5月、AbbVieは頬の肌の滑らかさを改善するジュビダームのスキンバイブのFDA承認を発表しました。この承認は、顔用注射剤における受容と革新の拡大を強調し、市場成長を促進し、治療に対する消費者の信頼を高めるものです。

さらに、顔用注射剤を含む美容施術の全体的な件数は着実に増加し続けており、その結果、市場の収益が増加しています。例えば、米国形成外科学会（ASPS）によると、2022年に米国では外科的および低侵襲的な美容整形手術が2,620万件が実施されており、2019年から19％の増加が見られました。このような外科的および低侵襲的美容施術の動向の高まりは、医療技術の進歩と注射剤の安全性プロファイルの改善によってもたらされています。これらの要因の組み合わせが相乗効果を生み出し、顔用注射剤市場内の需要を押し上げています。

顔用注射剤市場レポートハイライト

ヒアルロン酸（HA）セグメントは、効果的な美容強化のために広く採用されているため、2023年に最大の市場シェアを占めました。

唇増大術は、より豊かな唇、高度な技術、多様な製品オプションに対する消費者の需要に促進され、予測期間中に最も急成長する見込みです。

北米は、非侵襲的な治療と製品の革新により、美容施術の著しい成長を経験しており、2023年の顔用注射剤の世界市場で支配的な地域でした。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の顔用注射剤市場の洞察

  • 用途スナップショット
  • 顔用注射剤市場力学
    • 促進要因と機会
    • 抑制要因と課題
  • PESTEL分析
  • 顔用注射剤市場の用途動向
  • バリューチェーン分析
  • COVID-19の影響分析

第5章 世界の顔用注射剤市場：製品別

  • 主要な調査結果
  • イントロダクション
  • コラーゲン・PMMAマイクロスフィア
  • ボツリヌス毒素A型
  • ヒアルロン酸（HA）
  • カルシウムヒドロキシアパタイト（CaHA）
  • ポリ-L-乳酸（PLLA）
  • その他

第6章 世界の顔用注射剤市場：最終用途別

  • 主要な調査結果
  • イントロダクション
  • メディスパ
  • 皮膚科クリニック
  • 病院

第7章 世界の顔用注射剤市場：用途別

  • 主要な調査結果
  • イントロダクション
  • フェイスライン矯正
  • 唇の増大
  • フェイスリフト
  • ニキビ跡の治療
  • 脂肪萎縮症の治療
  • その他

第8章 世界の顔用注射剤市場：地域別

  • 主要な調査結果
  • イントロダクション
    • 顔用注射剤市場評価：地域別、2019年～2032年
  • 北米
    • 北米：製品別、2019年～2032年
    • 北米：用途別、2019年～2032年
    • 北米：最終用途別、2019年～2032年
    • 米国
    • カナダ
  • 欧州
    • 欧州：製品別、2019年～2032年
    • 欧州：用途別、2019年～2032年
    • 欧州：最終用途別、2019年～2032年
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • スペイン
    • オランダ
    • ロシア
    • その他欧州
  • アジア太平洋
    • アジア太平洋：製品別、2019年～2032年
    • アジア太平洋：用途別、2019年～2032年
    • アジア太平洋：最終用途別、2019年～2032年
    • 中国
    • インド
    • マレーシア
    • 日本
    • インドネシア
    • 韓国
    • オーストラリア
    • その他アジア太平洋
  • 中東・アフリカ
    • 中東・アフリカ：製品別、2019年～2032年
    • 中東・アフリカ：用途別、2019年～2032年
    • 中東・アフリカ：最終用途別、2019年～2032年
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東・アフリカ
  • ラテンアメリカ
    • ラテンアメリカ：製品別、2019年～2032年
    • ラテンアメリカ：用途別、2019年～2032年
    • ラテンアメリカ：最終用途別、2019年～2032年
    • メキシコ
    • ブラジル
    • アルゼンチン
    • その他ラテンアメリカ

第9章 競合情勢

  • 拡大と買収の分析
    • 拡大
    • 買収
  • 提携 / 協業 / 合意 / 公開

第10章 企業プロファイル

  • Allergan Aesthetics（AbbVie Inc.）
  • BIOPLUS CO., LTD.
  • Bioxis Pharmaceuticals
  • GALDERMA
  • Ipsen Pharma
  • Merz Pharma
  • Medytox
  • Prollenium Medical Technologies
  • SINCLAIR PLASTIC SURGERY
  • Teoxane
図表

List of Tables

  • Table 1 Global Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 2 Global Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 3 Global Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 4 Facial Injectable Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 5 North America: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 6 North America: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 7 North America: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 8 U.S.: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 9 U.S.: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 10 U.S.: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 11 Canada: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 12 Canada: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 13 Canada: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 14 Europe: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 15 Europe: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 16 Europe: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 17 UK: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 18 UK: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 19 UK: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 20 France: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 21 France: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 22 France: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 23 Germany: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 24 Germany: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 25 Germany: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 26 Italy: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 27 Italy: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 28 Italy: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 29 Spain: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 30 Spain: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 31 Spain: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 32 Netherlands: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 33 Netherlands: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 34 Netherlands: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 35 Russia: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 36 Russia: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 37 Russia: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 38 Rest of Europe: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 39 Rest of Europe: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 40 Rest of Europe: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 41 Asia Pacific: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 42 Asia Pacific: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 43 Asia Pacific: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 44 China: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 45 China: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 46 China: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 47 India: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 48 India: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 49 India: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 50 Malaysia: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 51 Malaysia: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 52 Malaysia: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 53 Japan: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 54 Japan: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 55 Japan: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 56 Indonesia: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 57 Indonesia: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 58 Indonesia: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 59 South Korea: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 60 South Korea: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 61 South Korea: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 62 Australia: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 63 Australia: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 64 Australia: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 65 Rest of Asia Pacific: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 66 Rest of Asia Pacific: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 67 Rest of Asia Pacific: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 68 Middle East & Africa: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 69 Middle East & Africa: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 70 Middle East & Africa: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 71 Saudi Arabia: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 72 Saudi Arabia: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 73 Saudi Arabia: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 74 UAE: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 75 UAE: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 76 UAE: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 77 Israel: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 78 Israel: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 79 Israel: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 80 South Africa: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 81 South Africa: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 82 South Africa: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 83 Rest of Middle East & Africa: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 84 Rest of Middle East & Africa: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 85 Rest of Middle East & Africa: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 86 Latin America: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 87 Latin America: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 88 Latin America: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 89 Mexico: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 90 Mexico: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 91 Mexico: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 92 Brazil: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 93 Brazil: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 94 Brazil: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 95 Argentina: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 96 Argentina: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 97 Argentina: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 98 Rest of Latin America: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 99 Rest of Latin America: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 100 Rest of Latin America: Facial Injectable Market, by Application, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Facial Injectable Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by End-use
  • Figure 7. Global Facial Injectable Market, by End-use, 2023 & 2032 (USD Billion)
  • Figure 8. Market by Product
  • Figure 9. Global Facial Injectable Market, by Product, 2023 & 2032 (USD Billion)
  • Figure 10. Market by Application
  • Figure 11. Global Facial Injectable Market, by Application, 2023 & 2032 (USD Billion)
  • Figure 12. Facial Injectable Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 13. Strategic Analysis - Facial Injectable Market
目次
Product Code: PM1307

The global facial injectable market size is expected to reach USD 33.63 billion by 2032, according to a new study by Polaris Market Research. The report "Global Facial Injectable Market Share, Size, Trends, Industry Analysis Report: Information By Product, By Application, By End-Use (MedSpa, Dermatology Clinics, Hospitals), And By Region (North America, Europe, Asia-Pacific, Middle East & Africa, And Latin America) - Market Forecast, 2024 - 2032." gives a detailed insight into current market dynamics and provides analysis on future market growth.

The demand for facial injectables is rapidly increasing due to the introduction of cost-effective procedures that have significantly expanded the market's demand. Products offer accessible options for consumers seeking aesthetic enhancements without high costs, thus widening the customer base and increasing overall market penetration.

Moreover, the growing demand for facial injectables is driven by increased regulatory approvals, that ensures safety, effectiveness and make treatments more accessible and appealing to a broader range of consumers. For instance, in May 2023, AbbVie announced the FDA approval of Juvederm's Skinvive to improve skin smoothness in the cheeks. This approval emphasizes the growing acceptance and innovation in facial injectables, driving market growth and enhancing consumer confidence in treatments.

Furthermore, the overall number of cosmetic procedures, including facial injectables, continues to rise steadily, in turn driving the market revenue. For instance, according to the American Society of Plastic Surgeons (ASPS), in 2022, the United States witnessed 26.2 million surgical and minimally invasive cosmetic procedures, observing a 19% increase since 2019. This rising trends for surgical and minimally invasive cosmetic procedures are driven by advancements in medical technology and improved safety profiles of injectable products. The combination of these factors creates a synergistic effect, boosting demand within the facial injectables market.

Facial Injectable Market Report Highlights

The hyaluronic acid (HA) segment held the largest market share in 2023 due to its widespread adoption for effective cosmetic enhancements.

The lip augmentation is expected to grow fastest over the forecast period, driven by consumer demand for fuller lips, advanced techniques, and diverse product options.

North America was the dominant region in the global facial injectables market in 2023, experiencing significant growth in cosmetic procedures due to non-invasive treatments and product innovations.

The global key market players include Allergan Aesthetics (AbbVie), BIOPLUS CO., LTD., Bioxis Pharmaceuticals, GALDERMA, Ipsen Pharma, Merz Pharma, Medytox, Prollenium Medical Technologies, SINCLAIR PLASTIC SURGERY, and Teoxane

Polaris Market Research has segmented the facial injectable market report based on product, application, end-use and region:

Facial Injectable, Product Outlook (Revenue - USD Billion, 2019 - 2032)

  • Collagen & PMMA Microspheres
  • Botulinum Toxin Type A
  • Hyaluronic Acid (HA)
  • Calcium Hydroxylapatite (CaHA)
  • Poly-L-lactic Acid (PLLA)
  • Others

Facial Injectable, Application Outlook (Revenue - USD Billion, 2019 - 2032)

  • Facial Line Correction
  • Lip Augmentation
  • Face Lift
  • Acne Scar Treatment
  • Lipoatrophy Treatment
  • Others

Facial Injectable, End-Use (Revenue - USD Billion, 2019 - 2032)

  • MedSpa
  • Dermatology Clinics
  • Hospitals

Facial Injectable, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Australia
  • Malaysia
  • Rest of Asia Pacific
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

1.Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Facial Injectable Market Insights

  • 4.1. Facial Injectable Market - Application Snapshot
  • 4.2. Facial Injectable Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. High rate of FDA approvals is a significant catalyst for facial injectables market growth
      • 4.2.1.2. Increasing adoption of facial injectables
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Adverse side effects of facial injectables
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Facial Injectable Market Application Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Facial Injectable Market, by Product

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • 5.3. Collagen & PMMA Microspheres
    • 5.3.1. Global Facial Injectable Market, by Collagen & PMMA Microspheres, by Region, 2019-2032 (USD Billion)
  • 5.4. Botulinum Toxin Type A
    • 5.4.1. Global Facial Injectable Market, by Botulinum Toxin Type A, by Region, 2019-2032 (USD Billion)
  • 5.5. Hyaluronic Acid (HA)
    • 5.5.1. Global Facial Injectable Market, by Hyaluronic Acid (HA), by Region, 2019-2032 (USD Billion)
  • 5.6. Calcium Hydroxylapatite (CaHA)
    • 5.6.1. Global Facial Injectable Market, by Calcium Hydroxylapatite (CaHA), by Region, 2019-2032 (USD Billion)
  • 5.7. Poly-L-lactic Acid (PLLA)
    • 5.7.1. Global Facial Injectable Market, by Poly-L-lactic Acid (PLLA), by Region, 2019-2032 (USD Billion)
  • 5.8. Others
    • 5.8.1. Global Facial Injectable Market, by Others, by Region, 2019-2032 (USD Billion)

6. Global Facial Injectable Market, by End-use

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • 6.3. MedSpa
    • 6.3.1. Global Facial Injectable Market, by MedSpa, by Region, 2019-2032 (USD Billion)
  • 6.4. Dermatology Clinics
    • 6.4.1. Global Facial Injectable Market, by Dermatology Clinics, by Region, 2019-2032 (USD Billion)
  • 6.5. Hospitals
    • 6.5.1. Global Facial Injectable Market, by Hospitals, by Region, 2019-2032 (USD Billion)

7. Global Facial Injectable Market, by Application

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • 7.3. Facial Line Correction
    • 7.3.1. Global Facial Injectable Market, by Facial Line Correction, By Region, 2019-2032 (USD Billion)
  • 7.4. Lip Augmentation
    • 7.4.1. Global Facial Injectable Market, by Lip Augmentation, By Region, 2019-2032 (USD Billion)
  • 7.5. Face Lift
    • 7.5.1. Global Facial Injectable Market, by Face Lift, By Region, 2019-2032 (USD Billion)
  • 7.6. Acne Scar Treatment
    • 7.6.1. Global Facial Injectable Market, by Acne Scar Treatment, By Region, 2019-2032 (USD Billion)
  • 7.7. Lipoatrophy Treatment
    • 7.7.1. Global Facial Injectable Market, by Lipoatrophy Treatment, By Region, 2019-2032 (USD Billion)
  • 7.8. Others
    • 7.8.1. Global Facial Injectable Market, by Others, By Region, 2019-2032 (USD Billion)

8. Global Facial Injectable Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Facial Injectable Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 8.3. Facial Injectable Market - North America
    • 8.3.1. North America: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
    • 8.3.2. North America: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
    • 8.3.3. North America: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
    • 8.3.4. Facial Injectable Market - U.S.
      • 8.3.4.1. U.S.: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
      • 8.3.4.2. U.S.: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
      • 8.3.4.3. U.S.: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
    • 8.3.5. Facial Injectable Market - Canada
      • 8.3.5.1. Canada: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
      • 8.3.5.2. Canada.: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
      • 8.3.5.3. Canada: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • 8.4. Facial Injectable Market - Europe
    • 8.4.1. Europe: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
    • 8.4.2. Europe.: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
    • 8.4.3. Europe: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
    • 8.4.4. Facial Injectable Market - UK
      • 8.4.4.1. UK: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
      • 8.4.4.2. UK.: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
      • 8.4.4.3. UK: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
    • 8.4.5. Facial Injectable Market - France
      • 8.4.5.1. France: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
      • 8.4.5.2. France.: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
      • 8.4.5.3. France: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
    • 8.4.6. Facial Injectable Market - Germany
      • 8.4.6.1. Germany: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
      • 8.4.6.2. Germany.: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
      • 8.4.6.3. Germany: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
    • 8.4.7. Facial Injectable Market - Italy
      • 8.4.7.1. Italy: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
      • 8.4.7.2. Italy.: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
      • 8.4.7.3. Italy: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
    • 8.4.8. Facial Injectable Market - Spain
      • 8.4.8.1. Spain: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
      • 8.4.8.2. Spain.: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
      • 8.4.8.3. Spain: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
    • 8.4.9. Facial Injectable Market - Netherlands
      • 8.4.9.1. Netherlands: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
      • 8.4.9.2. Netherlands.: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
      • 8.4.9.3. Netherlands: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
    • 8.4.10. Facial Injectable Market - Russia
      • 8.4.10.1. Russia: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
      • 8.4.10.2. Russia.: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
      • 8.4.10.3. Russia: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
    • 8.4.11. Facial Injectable Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
      • 8.4.11.2. Rest of Europe.: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
      • 8.4.11.3. Rest of Europe: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • 8.5. Facial Injectable Market - Asia Pacific
    • 8.5.1. Asia Pacific: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
    • 8.5.2. Asia Pacific.: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
    • 8.5.3. Asia Pacific: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
    • 8.5.4. Facial Injectable Market - China
      • 8.5.4.1. China: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
      • 8.5.4.2. China.: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
      • 8.5.4.3. China: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
    • 8.5.5. Facial Injectable Market - India
      • 8.5.5.1. India: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
      • 8.5.5.2. India.: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
      • 8.5.5.3. India: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
    • 8.5.6. Facial Injectable Market - Malaysia
      • 8.5.6.1. Malaysia: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
      • 8.5.6.2. Malaysia.: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
      • 8.5.6.3. Malaysia: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
    • 8.5.7. Facial Injectable Market - Japan
      • 8.5.7.1. Japan: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
      • 8.5.7.2. Japan.: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
      • 8.5.7.3. Japan: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
    • 8.5.8. Facial Injectable Market - Indonesia
      • 8.5.8.1. Indonesia: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
      • 8.5.8.2. Indonesia.: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
      • 8.5.8.3. Indonesia: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
    • 8.5.9. Facial Injectable Market - South Korea
      • 8.5.9.1. South Korea: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
      • 8.5.9.2. South Korea: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
      • 8.5.9.3. South Korea: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
    • 8.5.10. Facial Injectable Market - Australia
      • 8.5.10.1. Australia: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
      • 8.5.10.2. Australia: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
      • 8.5.10.3. Australia: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
    • 8.5.11. Facial Injectable Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
      • 8.5.11.2. Rest of Asia Pacific: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
      • 8.5.11.3. Rest of Asia Pacific: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • 8.6. Facial Injectable Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
    • 8.6.2. Middle East & Africa.: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
    • 8.6.3. Middle East & Africa: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
    • 8.6.4. Facial Injectable Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
      • 8.6.4.2. Saudi Arabia.: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
    • 8.6.5. Facial Injectable Market - UAE
      • 8.6.5.1. UAE: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
      • 8.6.5.2. UAE.: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
      • 8.6.5.3. UAE: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
    • 8.6.6. Facial Injectable Market - Israel
      • 8.6.6.1. Israel: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
      • 8.6.6.2. Israel.: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
      • 8.6.6.3. Israel: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
    • 8.6.7. Facial Injectable Market - South Africa
      • 8.6.7.1. South Africa: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
      • 8.6.7.2. South Africa.: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
      • 8.6.7.3. South Africa: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
    • 8.6.8. Facial Injectable Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
      • 8.6.8.2. Rest of Middle East & Africa: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
      • 8.6.8.3. Rest of Middle East & Africa: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • 8.7. Facial Injectable Market - Latin America
    • 8.7.1. Latin America: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
    • 8.7.2. Latin America.: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
    • 8.7.3. Latin America: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
    • 8.7.4. Facial Injectable Market - Mexico
      • 8.7.4.1. Mexico: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
      • 8.7.4.2. Mexico.: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
      • 8.7.4.3. Mexico: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
    • 8.7.5. Facial Injectable Market - Brazil
      • 8.7.5.1. Brazil: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
      • 8.7.5.2. Brazil.: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
      • 8.7.5.3. Brazil: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
    • 8.7.6. Facial Injectable Market - Argentina
      • 8.7.6.1. Argentina: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
      • 8.7.6.2. Argentina.: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
      • 8.7.6.3. Argentina: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
    • 8.7.7. Facial Injectable Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
      • 8.7.7.2. Rest of Latin America.: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
      • 8.7.7.3. Rest of Latin America: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Allergan Aesthetics (AbbVie Inc.)
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. BIOPLUS CO., LTD.
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Bioxis Pharmaceuticals
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. GALDERMA
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Ipsen Pharma
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Merz Pharma
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Medytox
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Prollenium Medical Technologies
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. SINCLAIR PLASTIC SURGERY
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Teoxane
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development